Browse Guides  internal medicine  haematology

Sickle cell crisis

Prevalence
Clinical features
Investigations
Therapy
Prevention
Prognosis
Therapy

Avoid regular administration of pethidine. c  

Why?

  • Patients with sickle cell disease who have levels of norpethidine >1.0mcg/l (a toxic metabolite of pethidine) are at increased risk of fitting. c

Pethidine increases the risk of a seizure

Outcome Risk Factor Peer OR
(95% CI)
NNH
(95% CI)
fit c norpethidine >1.0 mcg/l
not independent
-% -
(5.5 to infinity)
1
(1 to 200)

 

Expiry date: May 2004
Levels of Evidence used in grading these guides

Author    CM  Ball, RS Phillips
Reviewer   G   Serjeant
CAT Writer     CM  Ball, N  Shenker